Tirzepatide is administered as part of routine clinical care for obesity management, according to standard prescribing practices. Dosing and treatment duration are determined by the treating physician

DRUG2 trials

Sponsors

Azienda Sanitaria Locale Napoli 2 Nord, Zagazig University

Conditions

Obese DiabeticsObese Non DiabeticObesity & OverweightObesity, MorbidWeight Regain

Phase 3

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

CompletedNCT07820111

Zagazig UniversityObese Diabetics, Obese Non Diabetic

Start: 2025-10-18End: 2026-03-17Updated: 2026-09-15

Unknown Phase

Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients

CompletedNCT07382180

Azienda Sanitaria Locale Napoli 2 NordObesity, Morbid, Obesity & Overweight, Weight Regain

Start: 2025-02-01End: 2026-01-18Updated: 2026-02-03